tobrex 3 mg/1 g mast za oči
novartis ba d.o.o. - na primjeru тобрамицина - mast za oči - 3 mg/1 g - 1 g masti za oči sadrži: 3 mg tobramicina
tobrex 3 mg/1 ml kapi za oko, otopina
novartis ba d.o.o. - na primjeru тобрамицина - kapi za oko, otopina - 3 mg/1 ml - 1 ml kapi za oko, otopine sadrži: 3 mg tobramicina
oftamycin 3 mg/1 ml kapi za oko, otopina
unifarm d.o.o. lukavac - na primjeru тобрамицина - kapi za oko, otopina - 3 mg/1 ml - 1 ml kapi za oko, otopine sadrži: 3 mg tobramicina
ergometer installation and training
kardian d.o.o. hondlova 2/9 10000 zagreb -
glimatin 100 mg/1 tableta film tableta
galenika d.o.o. - imatinib - film tableta - 100 mg/1 tableta - 1 film tableta sadrži: 100 mg imatiniba (u obliku imatinibmesilata)
glimatin 400 mg/1 tableta film tableta
galenika d.o.o. - imatinib - film tableta - 400 mg/1 tableta - 1 film tableta sadrži: 400 mg imatiniba (u obliku imatinibmesilata)
revolade
novartis europharm limited - eltrombopag - purpura, trombocitopenična, idiopatska - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
slenyto
rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders; autistic disorder - psycholeptics - slenyto indiciran za liječenje nesanice kod djece i adolescenata u dobi od 2 do 18 s poremećajem autističnog spektra (asd) i / ili smith-magenis sindrom, gdje spavati higijenske mjere su dovoljne.
paliperidon teva 100 mg suspenzija za injekciju s produljenim oslobađanjem
teva b.v., swensweg 5, haarlem, nizozemska - paliperidonpalmitat - suspenzija za injekciju s produljenim oslobađanjem - urbroj: jedna napunjena štrcaljka sadrži 156 mg paliperidonpalmitata što odgovara 100 mg paliperidona